Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Impact Analysis of Market Dynamics
4.2.1.1. Increasing Applications of Spatial Genomics in Drug Discovery & Development Driving Market Growth
4.2.1.2. Lack of Standardization and Concerns Over the Privacy of Genomic Data Limiting the Adoption of Spatial Genomics Products
4.2.1.3. Rising Adoption of Personalized Medicines Generating Growth Opportunities for Market Players
4.2.1.4. Complexities in Data Analysis to Remain a Major Challenge Impacting Market Growth
4.2.2. Factor Analysis
4.3. Technology Trends
4.3.1. Integration of Artificial Intelligence (AI) in Spatial Genomics
4.3.2. Multiplexed Spatial Genomics
4.4. Investment and Funding Scenario
4.5. Pricing Analysis
4.6. Porter’s Five Forces Analysis
4.6.1. Bargaining Power of Buyers
4.6.2. Bargaining Power of Suppliers
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Degree of Competition

5. Spatial Genomics & Transcriptomics Market Assessment?by Offering
5.1. Overview
5.2. Instruments
5.3. Consumables
5.4. Software & Services

6. Spatial Genomics & Transcriptomics Market Assessment?by Type
6.1. Overview
6.2. Transcriptomics
6.3. Genomics

7. Spatial Genomics & Transcriptomics Market Assessment ?by Technology
7.1. Overview
7.2. Imaging Based
7.3. Sequencing Based

8. Spatial Genomics & Transcriptomics Market Assessment ?by Application
8.1. Overview
8.2. Oncology
8.3. Neurology
8.4. Other Applications

9. Spatial Genomics & Transcriptomics Market Assessment ?by End User
9.1. Overview
9.2. Pharmaceutical & Biotechnology Companies
9.3. Contract Research Organizations
9.4. Other End Users

10. Spatial Genomics & Transcriptomics Market Assessment?by Geography
10.1. Overview
10.2. North America
10.2.1. U.S.
10.2.2. Canada
10.3. Europe
10.3.1. Germany
10.3.2. France
10.3.3. U.K.
10.3.4. Italy
10.3.5. Spain
10.3.6. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Rest of Asia-Pacific
10.5. Latin America
10.6. Middle East & Africa

11. Competition Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Competitive Benchmarking
11.4. Competitive Dashboard
11.4.1. Industry Leaders
11.4.2. Differentiators
11.4.3. Vanguards
11.4.4. Emerging Companies
11.5. Market Share Analysis
11.5.1. 10X Genomics, Inc. (U.S.)
11.5.2. NanoString Technologies, Inc. (U.S.)
11.5.3. Akoya Biosciences, Inc. (U.S.)

12. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, and SWOT Analysis)
12.1. 10X Genomics, Inc.
12.2. NanoString Technologies, Inc.
12.3. Akoya Biosciences, Inc.
12.4. Illumina, Inc.
12.5. Oxford Nanopore Technologies Plc
12.6. Revvity, Inc.
12.7. S2 Genomics, Inc.
12.8. Cantata Bio
12.9. Vizgen Inc.
12.10. Biospyder Technologies Inc.
12.11 Resolve Biosciences GmbH
(Note: SWOT Analysis of Top 5 Companies is Provided)

13. Appendix
13.1. Available Customization
13.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Spatial Genomics & Transcriptomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 8 Global Spatial Genomics & Transcriptomics Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Spatial Genomics & Transcriptomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 10 Global Spatial Genomics & Transcriptomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 11 Global Spatial Genomics & Transcriptomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 12 Spatial Genomics & Transcriptomics Market, by Geography
Figure 13 Impact Analysis of Market Dynamics
Figure 14 Global Pharmaceutical R&D Expenditure, 2012–2026 (USD Billion)
Figure 15 Estimated Number of New Cancer Cases, by Region, 2020 Vs. 2030 (In Thousand)
Figure 16 Global Increase in The Number of Personalized Medicine Approvals, 2008–2020
Figure 17 Porter’s Five Forces Analysis
Figure 18 Global Spatial Genomics & Transcriptomics Market, by Offering, 2024 Vs. 2031 (USD Million)
Figure 19 Global Spatial Genomics & Transcriptomics Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 20 Global Spatial Genomics & Transcriptomics Market, by Technology, 2024 Vs. 2031 (USD Million)
Figure 21 Imaging Based Methods: Workflow
Figure 22 Sequencing Based Methods: Workflow
Figure 23 Global Spatial Genomics & Transcriptomics Market, by Application, 2024 Vs. 2031 (USD Million)
Figure 24 Global Spatial Genomics & Transcriptomics Market, by End User, 2024 Vs. 2031 (USD Million)
Figure 25 Global Pharmaceutical R&D Spending, 2012–2026 (USD Billion)
Figure 26 Global Spatial Genomics & Transcriptomics Market, by Region, 2024 Vs. 2031 (USD Million)
Figure 27 North America: Spatial Genomics & Transcriptomics Market Snapshot
Figure 28 U.S.: Pharmaceutical R&D Expenditures, 2014-2021 (USD Billion)
Figure 29 Europe: Pharmaceutical R&D Expenditures, 2000-2021 (USD Million)
Figure 30 Europe: Spatial Genomics & Transcriptomics Market Snapshot
Figure 31 Roe: Countries Pharmaceutical R&D Expenditures, 2021 (USD Million)
Figure 32 Asia-Pacific: Spatial Genomics Market Snapshot
Figure 33 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 34 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking (Based on Offering)
Figure 35 Spatial Genomics & Transcriptomics Market: Competitive Benchmarking (Based on Geography)
Figure 36 Competitive Dashboard: Spatial Genomics & Transcriptomics Market
Figure 37 Global Spatial Genomics & Transcriptomics Market Share Analysis, by Key Players (2023)
Figure 38 10x Genomics, Inc.: Financial Overview (2022)
Figure 39 NanoString Technologies, Inc.: Financial Overview (2022)
Figure 40 Akoya Biosciences, Inc.: Financial Overview (2022)
Figure 41 Illumina, Inc.: Financial Overview (2022)
Figure 42 Oxford Nanopore Technologies Plc.: Financial Overview (2022)
Figure 43 PerkinElmer, Inc: Financial Overview (2022)

List of Tables

Table 1 Estimated Number of New Cancer Cases, by Type, 2020 Vs. 2030
Table 2 Recent Investments and Funding in The Spatial Genomics & Transcriptomics Market
Table 3 Spatial Genomics & Transcriptomics Instruments: Pricing (USD/Unit)
Table 4 Spatial Genomics & Transcriptomics Consumables: Pricing (USD/Unit)
Table 5 Global Spatial Genomics & Transcriptomics Market, by Offering, 2022-2031 (USD Million)
Table 6 Key Companies Offering Instruments
Table 7 Global Spatial Genomics & Transcriptomics Market for Instruments, by Country/Region, 2022-2031 (USD Million)
Table 8 Key Companies Offering Consumables
Table 9 Global Spatial Genomics & Transcriptomics Market for Consumables, by Country/Region, 2022-2031 (USD Million)
Table 10 Key Companies Offering Software
Table 11 Global Spatial Genomics & Transcriptomics Market for Software & Services, by Country/Region, 2022-2031 (USD Million)
Table 12 Global Spatial Genomics & Transcriptomics Market, by Type, 2022-2031 (USD Million)
Table 13 Global Spatial Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
Table 14 Spatial Genomics: Key Application Areas
Table 15 Global Spatial Genomics Market, by Country/Region, 2022-2031 (USD Million)
Table 16 Global Spatial Genomics & Transcriptomics Market, by Technology, 2022-2031 (USD Million)
Table 17 Global Imaging Based Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
Table 18 Global Sequencing Based Spatial Genomics & Transcriptomics Market, by Country/Region, 2022-2031 (USD Million)
Table 19 Global Spatial Genomics & Transcriptomics Market, by Application, 2022-2031 (USD Million)
Table 20 Global Spatial Genomics & Transcriptomics Market for Oncology, by Country/Region, 2022-2031 (USD Million)
Table 21 Global Spatial Genomics & Transcriptomics Market for Neurology, by Country/Region, 2022-2031 (USD Million)
Table 22 Global Spatial Genomics & Transcriptomics Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
Table 23 Global Spatial Genomics & Transcriptomics Market, by End User, 2022-2031 (USD Million)
Table 24 Global Spatial Genomics & Transcriptomics Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
Table 25 Global Spatial Genomics & Transcriptomics Market for Contract Research Organizations, by Country/Region, 2022-2031 (USD Million)
Table 26 Global Spatial Genomics & Transcriptomics Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
Table 27 Global Spatial Genomics & Transcriptomics Market, by Country/Region, 2022–2031 (USD Million)
Table 28 North America: Spatial Genomics & Transcriptomics Market, by Country, 2022–2031 (USD Million)
Table 29 North America: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 30 North America: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 31 North America: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 32 North America: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 33 North America: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 34 U.S.: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 35 U.S.: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 36 U.S.: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 37 U.S.: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 38 U.S.: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 39 Canada: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 40 Canada: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 41 Canada: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 42 Canada: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 43 Canada: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 44 Europe: Spatial Genomics & Transcriptomics Market, by Country/Region, 2022–2031 (USD Million)
Table 45 Europe: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 46 Europe: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 47 Europe: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 48 Europe: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 49 Europe: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 50 Germany: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 51 Germany: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 52 Germany: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 53 Germany: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 54 Germany: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 55 France: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 56 France: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 57 France: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 58 France: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 59 France: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 60 U.K.: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 61 U.K.: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 62 U.K.: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 63 U.K.: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 64 U.K.: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 65 Italy: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 66 Italy: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 67 Italy: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 68 Italy: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 69 Italy: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 70 Spain: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 71 Spain: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 72 Spain: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 73 Spain: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 74 Spain: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 75 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Offering, 2022–2031 (USD Million)
Table 76 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Type, 2022–2031 (USD Million)
Table 77 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Technology, 2022–2031 (USD Million)
Table 78 Rest of Europe: Spatial Genomics & Transcriptomics Market, by Application, 2022–2031 (USD Million)
Table 79 Rest of Europe: Spatial Genomics & Transcriptomics Market, by End User, 2022–2031 (USD Million)
Table 80 Asia-Pacific: Spatial Genomics Market, by Country/Region, 2022–2031 (USD Million)
Table 81 Asia-Pacific: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 82 Asia-Pacific: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 83 Asia-Pacific: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 84 Asia-Pacific: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 85 Asia-Pacific: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 86 China: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 87 China: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 88 China: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 89 China: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 90 China: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 91 Japan: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 92 Japan: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 93 Japan: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 94 Japan: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 95 Japan: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 96 India: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 97 India: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 98 India: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 99 India: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 100 India: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 101 Rest of Asia-Pacific: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 102 Rest of Asia-Pacific: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 103 Rest of Asia-Pacific: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 104 Rest of Asia-Pacific: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 105 Rest of Asia-Pacific: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 106 Latin America: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 107 Latin America: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 108 Latin America: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 109 Latin America: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 110 Latin America: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 111 Middle East & Africa: Spatial Genomics Market, by Offering, 2022–2031 (USD Million)
Table 112 Middle East & Africa: Spatial Genomics Market, by Type, 2022–2031 (USD Million)
Table 113 Middle East & Africa: Spatial Genomics Market, by Technology, 2022–2031 (USD Million)
Table 114 Middle East & Africa: Spatial Genomics Market, by Application, 2022–2031 (USD Million)
Table 115 Middle East & Africa: Spatial Genomics Market, by End User, 2022–2031 (USD Million)
Table 116 Recent Developments, by Company, 2020–2023